We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
-$39.5M
Cap. Flow %
-27.17%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Buys

1
CNC icon
Centene
CNC
+$6.93M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.78M
3
UNH icon
UnitedHealth
UNH
+$3.65M
4
CVS icon
CVS Health
CVS
+$3.53M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M

Top Sells

1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

1 Healthcare 48.9%
2 Financials 13.82%
3 Technology 6.61%
4 Consumer Discretionary 5.8%
5 Materials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAIL
26
SailPoint Inc
SAIL
$8.89B
$1.53M 1.05%
+69,161
New +$1.45M
EHAB
27
DELISTED
Enhabit
EHAB
$1.49M 1.02%
185,594
-20,389
-10% -$153K
INDV icon
28
Indivior Pharmaceuticals
INDV
$4.79B
$1.41M 0.97%
+58,409
New +$1.22M
BMY icon
29
Bristol-Myers Squibb
BMY
$124B
$1.34M 0.92%
+29,793
New +$1.39M
RBRK icon
30
Rubrik
RBRK
$16.3B
$1.32M 0.9%
+16,000
New +$1.38M
THC icon
31
Tenet Healthcare
THC
$16.8B
$1.31M 0.9%
6,456
-6,065
-48% -$1.08M
ASND icon
32
Ascendis Pharma A/S
ASND
$17.1B
$1.26M 0.86%
+6,330
New +$1.18M
BABA icon
33
Alibaba
BABA
$276B
$1.25M 0.86%
+7,000
New +$917K
NBIX icon
34
Neurocrine Biosciences
NBIX
$17.2B
$1.22M 0.84%
8,694
-12,931
-60% -$1.75M
HSAI
35
Hesai Group
HSAI
$2.36B
$1.21M 0.83%
+43,226
New +$1.06M
VKTX icon
36
Viking Therapeutics
VKTX
$4.31B
$1.17M 0.81%
44,578
-904
-2% -$27K
C icon
37
Citigroup
C
$217B
$1.15M 0.79%
11,366
-5,067
-31% -$481K
FBK icon
38
FB Financial Corp
FBK
$3B
$1.14M 0.78%
+20,455
New +$1.04M
SF
39
Stifel
SF
$11.8B
$1.13M 0.78%
14,999
+7,962
+113% +$596K
AX icon
40
Axos Financial
AX
$5.66B
$1.08M 0.74%
12,729
-6,052
-32% -$527K
INTC icon
41
Intel
INTC
$478B
$1.07M 0.74%
32,000
+22,000
+220% +$533K
ETHA
42
iShares Ethereum Trust ETF
ETHA
$5.09B
$1.05M 0.72%
33,218
-52,679
-61% -$1.56M
IMCR icon
43
Immunocore
IMCR
$1.78B
$1.04M 0.71%
28,615
+4,577
+19% +$156K
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$35.7B
$1.03M 0.71%
+2,252
New +$917K
HBM icon
45
Hudbay
HBM
$9.04B
$1.03M 0.71%
67,754
-55,398
-45% -$634K
HCA icon
46
HCA Healthcare
HCA
$82.3B
$1M 0.69%
+2,353
New +$912K
CFLT
47
DELISTED
Confluent
CFLT
$990K 0.68%
50,000
+30,000
+150% +$627K
CCB icon
48
Coastal Financial
CCB
$1.2B
$983K 0.68%
9,091
-7,341
-45% -$778K
NKTR icon
49
Nektar Therapeutics
NKTR
$2.31B
$983K 0.68%
+17,270
New +$572K
NWS icon
50
News Corp Class B
NWS
$17.6B
$951K 0.65%
+27,513
New +$929K
1
2
3 4 5

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.